Black Rock Inc. Aim Immuno Tech Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Black Rock Inc. holds 698,267 shares of AIM stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
698,267
Previous 698,333
0.01%
Holding current value
$1.84 Million
Previous $328,000
21.34%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AIM
# of Institutions
6Shares Held
700KCall Options Held
0Put Options Held
0-
Advisor Group Holdings, Inc. Phoenix, AZ1KShares$2,6320.0% of portfolio
-
Cordasco Financial Network500Shares$1,3150.0% of portfolio
-
American Portfolios Advisors Holbrook, NY228Shares$5990.0% of portfolio
-
Jpmorgan Chase & CO New York, NY127Shares$3340.0% of portfolio
-
Mai Capital Management27Shares$710.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $126M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...